Table 6.

Comparison of Our Findings With the INWORKS Study

Fallout Dummy	(1)Estimated mSv in 20 Years (mSv)	(2) Excess Relative Risk (p.p) INWORKS	(3) Excess Relative Risk (p.p) Random Effects Baseline Controls	(4) Excess Relative Risk (p.p) Random Effects Additional Controls
${\text{D}}_{F1}$ (2<${\text{D}}_{F1}$<10	1.35	0.07 (0.02)	0.54 (0.14)	0.33 (0.16)
kBq/m2)
${\text{D}}_{F2}$ (10<${\text{D}}_{F2}$<40	6.75	0.34 (0.12)	0.63 (0.12)	0.40 (0.17)
kBq/m2)
${\text{D}}_{F3}$ (40<${\text{D}}_{F3}$<185	29.73	1.48 (0.53)	1.26 (0.21)	0.91 (0.25)
kBq/m2)

Column 1 indicates the approximate mSv dose for each fallout category for 20 years of exposure assuming shielding. Column 2 indicates the excess relative risk implied by the INWORKS study.4 Columns 3 and 4 display the approximate excess relative risk calculated using the hospital discharges for neoplasms in excess resulting from the estimates of the Random Effects models of column 2 in Tables 1 and 2, respectively, adjusted by the average number of per capita hospital discharges in zero fallout areas, equal to 1.08. Standard errors in parentheses.